Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Tatva Chintan Pharma Chem Limited ( (IN:TATVA) ) has issued an announcement.
Tatva Chintan Pharma Chem Limited has released the transcript of its Q3 FY26 earnings conference call held on 21 January 2026, following the announcement of its financial results for the quarter and nine months ended 31 December 2025. The company notified stock exchanges that the detailed call transcript, featuring commentary from senior management including the managing director, chief financial officer and finance leadership, has been made available on its website, improving disclosure and access to performance insights for investors and other stakeholders.
More about Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited operates in the specialty chemicals and pharmaceutical intermediates space, supplying high-value chemical products to domestic and international customers. The company is listed on both BSE and NSE under the symbol TATVA, reflecting its access to capital markets and its positioning as a publicly traded player in India’s chemical and pharma value chain.
Average Trading Volume: 7,517
Technical Sentiment Signal: Buy
Current Market Cap: 29.83B INR
Learn more about TATVA stock on TipRanks’ Stock Analysis page.